Connect with us
The objective of this first round of investment is to complete the development of the platform through which the company will provide services, with special attention...
Better works with healthcare professionals to determine which type of medications are best for patients, after having analyzed and parameterized their data. The company's platform, Better Meds, provides...
To date, Ephion has agreements with five hospitals for the implementation of its Ephion Mobility technology in neuromuscular diseases: the Sant Joan de Deu Hospital, the...
Sicit specializes in the transformation of leather by-products into biostimulants for agriculture and retardants for the gypsum industry. The company offers a strategically important service for...
The company, which has 37 people on its staff, generates 80% of its turnover in the Spanish market and the remaining 20% in various international markets, including...
Qubiotech uses Artificial Intelligence-based image processing to develop diagnostics for brain diseases, which it has called Neurocloud. The software hosts three medical image quantification algorithms (PET,...
Once this round is completed, Mikrobiomik plans to initiate a new financing round with the aim of raising €6 million, in which it plans to include...
Boehringer Ingelheim reached a sales figure of €24.1 billion in 2022, which translates into a year-on-year rise of 10.5%. In 2022, the Spanish subsidiary registered an...
Prim aims to achieve sales of €305 million by 2025. The company founded in 1870 expects that by that date 25% of its business will come...
Galenicum Axium, a subsidiary that focuses on the development of licenses and distribution of medicines for other companies and is one of the company's main sources...